All patients who started abacavir were observed for 6 weeks. To immunologically confirm, and enhance the specificity of, the clinical diagnosis of hypersensitivity reaction to abacavir ...

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

The company’s mission is to use high-throughput, multiplexable genome editing in combination with expertise in transplantation immunology to create immunologically privileged allogeneic cells ...

Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer. Association of immune microenvironment to response in treatment-naïve non-small cell lung cancer (NSCLC) ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

Pediatric high-grade gliomas are largely immunologically silent or “cold,” with few tumor-infiltrating lymphocytes. Preclinically, pediatric brain tumors are highly sensitive to oncolytic ...

Journal of Clinical Investigation. (2009, August 14). How Mice And Humans Differ Immunologically. ScienceDaily. Retrieved May 28, 2025 from www.sciencedaily.com / releases / 2009 / 08 ...

Differences in the immune microenvironment between early and late-onset colon and rectal cancer. Feasibility and clinical impact of routine molecular testing of gastrointestinal (GI) cancers at a ...

Essentially, our new therapy makes immunologically 'cold' tumors hot enough for the immune system to attack and destroy them." Claudia Gravekamp, Ph.D., corresponding author of the paper and ...